Dr. Sivaram Neppala, MD
Claim this profileTexas Diabetes Institute - University Health System
Studies Heart Failure
Studies Diabetes
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Sivaram Neppala, MD is currently running
SGLT2 Inhibitors
for Heart Failure
This trial uses empagliflozin to help people with Type 2 Diabetes and Heart Failure. The medication increases blood ketone levels, which may improve muscle and heart function, exercise capacity, and overall well-being. Empagliflozin has been shown to reduce cardiovascular death and hospitalization for heart failure in patients with type 2 diabetes.
Recruiting0 awards Phase < 19 criteria
Pioglitazone
for Heart Failure in Type 2 Diabetes
Our goal of the study is to learn the effects of the diabetes medication named Pioglitazone, in type-2 diabetic obese participants with Heart failure. The main question it aims to answer are: 1. To demonstrate that impaired mitochondrial function leading to reduced ATP generation plays a key pathophysiologic role in the development of heart failure with preserved ejection fraction (HFpEF) in obese type 2 diabetic (T2D) individuals. 2. To demonstrate that pioglitazone, improves diastolic (as well as systolic) function by improving myocardial insulin sensitivity and by reducing both myocardial and epicardial fat content.
Recruiting2 awards Phase 412 criteria
More about Sivaram Neppala, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sivaram Neppala, MD has experience with
- Placebo
- Empagliflozin 25 MG
- Pioglitazone
- Empagliflozin
- Ketones
Breakdown of trials Sivaram Neppala, MD has run
Heart Failure
Diabetes
Type 2 Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sivaram Neppala, MD specialize in?
Sivaram Neppala, MD focuses on Heart Failure and Diabetes. In particular, much of their work with Heart Failure has involved treating patients, or patients who are undergoing treatment.
Is Sivaram Neppala, MD currently recruiting for clinical trials?
Yes, Sivaram Neppala, MD is currently recruiting for 2 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Sivaram Neppala, MD has studied deeply?
Yes, Sivaram Neppala, MD has studied treatments such as Placebo, Empagliflozin 25 MG, Pioglitazone.
What is the best way to schedule an appointment with Sivaram Neppala, MD?
Apply for one of the trials that Sivaram Neppala, MD is conducting.
What is the office address of Sivaram Neppala, MD?
The office of Sivaram Neppala, MD is located at: Texas Diabetes Institute - University Health System, San Antonio, Texas 78207 United States. This is the address for their practice at the Texas Diabetes Institute - University Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.